Trials / Unknown
UnknownNCT06021886
CS Scar Impact on ART Outcomes
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 510 (estimated)
- Sponsor
- HealthPlus Fertility Center · Academic / Other
- Sex
- Female
- Age
- 25 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
CS scar impact on ART outcomes, Retrospective Cohort Study IVF outcome can be affected by the presence of caesarean section scar with or without defect in different ways
Detailed description
CS scar impact on ART outcomes, Retrospective Cohort Study IVF outcome can be affected by the presence of caesarean section scar with or without defect in different ways; increase difficulty of embryo transfer, presence intrauterine fluid at the time of transfer can affect the chances of embryo implantation and increase the rate of spontaneous miscarriages To compare the success rates and outcomes of pregnancies of frozen embryo transfer for euploid embryos in patients without caesarean section, and who had caesarean section (with or without a NICHE) after euploid embryo transfer. Does CS scar and CS scar defect affect IVF outcome? All women who underwent an embryo transfer with a Euploid embryo between 2015 and 2022, who meet the inclusion criteria will be included in the study. * Inclusion Criteria: Age 25-40 years old. Euploid embryo transfer. Medically free BMI less tha 30 kg/m2 Hormone therapy preparation for FET. * Exclusion criteria Previous uterine scar other than cesarean section. Congenital uterine abnormalities Presence of intrauterine lesions e.g., polyp, fibroid, Endometriosis or adenomyosis Hydrosalpinx, Chronic endometritis * Primary outcome: Clinical pregnancy rate, defined as a pregnancy with a detectable heart rate at 7 weeks of gestation or beyond. * Secondary outcomes : Early pregnancy complications Ectopic pregnancy or Miscarriage. Caesarean section scar dehiscence or
Conditions
Timeline
- Start date
- 2023-06-15
- Primary completion
- 2024-01-01
- Completion
- 2024-01-01
- First posted
- 2023-09-01
- Last updated
- 2023-11-21
Locations
1 site across 1 country: United Arab Emirates
Source: ClinicalTrials.gov record NCT06021886. Inclusion in this directory is not an endorsement.